Covid-19 vaccine trial participant had serious neurological symptoms, AstraZeneca CEO says
September 09, 2020 at 12:18 PM EDT
The participant who triggered a global shutdown of AstraZeneca's Phase 3 Covid-19 vaccine trials was a woman in the United Kingdom who experienced neurological symptoms consistent with a rare but serious spinal inflammatory disorder called transverse myelitis.